Tandem Diabetes Care (TNDM) Consolidated Net Income (2016 - 2025)
Historic Consolidated Net Income for Tandem Diabetes Care (TNDM) over the last 13 years, with Q3 2025 value amounting to -$21.1 million.
- Tandem Diabetes Care's Consolidated Net Income rose 906.63% to -$21.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$203.4 million, marking a year-over-year decrease of 6039.75%. This contributed to the annual value of -$96.0 million for FY2024, which is 5686.42% up from last year.
- According to the latest figures from Q3 2025, Tandem Diabetes Care's Consolidated Net Income is -$21.1 million, which was up 906.63% from -$52.4 million recorded in Q2 2025.
- Tandem Diabetes Care's Consolidated Net Income's 5-year high stood at $10.8 million during Q4 2021, with a 5-year trough of -$130.6 million in Q1 2025.
- Moreover, its 5-year median value for Consolidated Net Income was -$23.3 million (2024), whereas its average is -$31.7 million.
- In the last 5 years, Tandem Diabetes Care's Consolidated Net Income surged by 16089.63% in 2021 and then crashed by 95194.85% in 2022.
- Over the past 5 years, Tandem Diabetes Care's Consolidated Net Income (Quarter) stood at $10.8 million in 2021, then plummeted by 247.28% to -$15.9 million in 2022, then crashed by 89.03% to -$30.0 million in 2023, then soared by 102.59% to $775000.0 in 2024, then tumbled by 2828.13% to -$21.1 million in 2025.
- Its Consolidated Net Income stands at -$21.1 million for Q3 2025, versus -$52.4 million for Q2 2025 and -$130.6 million for Q1 2025.